Public device page
MAP-AD Test Software - Frontend
Record
- UDI-DI
- 08437026887124
- Basic UDI-DI
- 8437026887AD002YK
- Status
- On the market
- Risk class
- Class C
- Reference
- AD002
- Version
- 1
- Manufacturer
- ADmit Therapeutics
- Manufacturer SRN
- ES-MF-000042518
- Manufacturer status
- Active
Last read from the public register: 2026-10-28T23:40:53+00:00.
UdiWatch is independent and not affiliated with the European Commission. This page shows our last read of the public EUDAMED register. If it differs from EUDAMED, EUDAMED is right.

UdiWatch